Idarubicin/cytosine arabinoside and mitoxantrone/etoposide with rhGM-CSF priming for de novo acute myelogenous leukemia
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Chapter/Article |
| Language: | English |
| Published: |
1994
|
| In: |
Acute leukemias ; 4: Prognostic factors and treatment strategies
Year: 1994, Pages: 575-577 |
| Online Access: |
|
| Author Notes: | Rainer Haas, Werner Hunstein |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1925769925 | ||
| 003 | DE-627 | ||
| 005 | 20251119100715.0 | ||
| 007 | tu | ||
| 008 | 250515s1994 xx ||||| 00| ||eng c | ||
| 035 | |a (DE-627)1925769925 | ||
| 035 | |a (DE-599)KXP1925769925 | ||
| 035 | |a (OCoLC)1528045477 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Haas, Rainer |d 1955- |e VerfasserIn |0 (DE-588)173773524 |0 (DE-627)698678141 |0 (DE-576)134613805 |4 aut | |
| 245 | 1 | 0 | |a Idarubicin/cytosine arabinoside and mitoxantrone/etoposide with rhGM-CSF priming for de novo acute myelogenous leukemia |c Rainer Haas, Werner Hunstein |
| 264 | 1 | |c 1994 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Hunstein, Werner |d 1928-2012 |e VerfasserIn |0 (DE-588)1012782662 |0 (DE-627)699775833 |0 (DE-576)345935667 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acute leukemias ; 4: Prognostic factors and treatment strategies |d Berlin : Springer, 1994 |g (1994), Seite 575-577 |h XXXVI, 803 S. |w (DE-627)1108007767 |w (DE-576)038007762 |z 3540569510 |z 0387569510 |7 nnam |a Idarubicin/cytosine arabinoside and mitoxantrone/etoposide with rhGM-CSF priming for de novo acute myelogenous leukemia |
| 773 | 1 | 8 | |g year:1994 |g pages:575-577 |g extent:3 |a Idarubicin/cytosine arabinoside and mitoxantrone/etoposide with rhGM-CSF priming for de novo acute myelogenous leukemia |
| 951 | |a AR | ||
| 992 | |a 20250515 | ||
| 993 | |a BookComponentPart | ||
| 994 | |a 1994 | ||
| 998 | |g 1012782662 |a Hunstein, Werner |m 1012782662:Hunstein, Werner |d 910000 |d 910100 |e 910000PH1012782662 |e 910100PH1012782662 |k 0/910000/ |k 1/910000/910100/ |p 2 |y j | ||
| 998 | |g 173773524 |a Haas, Rainer |m 173773524:Haas, Rainer |d 910000 |d 910100 |e 910000PH173773524 |e 910100PH173773524 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1925769925 |e 4724754885 | ||
| BIB | |a Y | ||
| JSO | |a {"type":{"bibl":"chapter"},"id":{"eki":["1925769925"]},"physDesc":[{"extent":"3 S."}],"title":[{"title_sort":"Idarubicin/cytosine arabinoside and mitoxantrone/etoposide with rhGM-CSF priming for de novo acute myelogenous leukemia","title":"Idarubicin/cytosine arabinoside and mitoxantrone/etoposide with rhGM-CSF priming for de novo acute myelogenous leukemia"}],"person":[{"family":"Haas","display":"Haas, Rainer","role":"aut","given":"Rainer"},{"given":"Werner","role":"aut","display":"Hunstein, Werner","family":"Hunstein"}],"language":["eng"],"relHost":[{"relMultPart":[{"part":{"number_sort":["4"],"number":["4"]},"ga":1,"id":{"eki":["1092296352"]},"type":{"bibl":"edited-book"},"title":[{"title_sort":"Acute leukemias","title":"Acute leukemias"}],"person":[{"given":"Thomas","display":"Büchner, Thomas","role":"edt","family":"Büchner"}],"note":["Literaturangaben"],"language":["eng"],"origin":[{"dateIssuedDisp":"19XX-","publisher":"Springer","publisherPlace":"Berlin ; Heidelberg [u.a.]"}],"recId":"1092296352","name":{"displayForm":["T. Büchner ... (eds.)"]}},{"language":["ger","eng"],"part":{"number":["36"],"number_sort":["36"]},"type":{"bibl":"serial"},"title":[{"title_sort":"Haematology and blood transfusion","subtitle":" = Hämatologie und Bluttransfusion","title":"Haematology and blood transfusion"}],"dispAlt":"Haematology and blood transfusion","origin":[{"publisherPlace":"Berlin ; Heidelberg [u.a.]","publisher":"Springer","dateIssuedDisp":"1977-2003","dateIssuedKey":"1977"}],"recId":"130710954","ga":1,"titleTranslated":[{"translated":"Hämatologie und Bluttransfusion"}],"id":{"eki":["130710954"],"zdb":["965096-9"]},"disp":"Haematology and blood transfusion","pubHistory":["20.1977 - 41.2003[?]"]}],"language":["eng"],"person":[{"given":"Thomas","role":"edt","display":"Büchner, Thomas","family":"Büchner"}],"origin":[{"dateIssuedDisp":"1994","dateIssuedKey":"1994","publisherPlace":"Berlin ; Heidelberg","publisher":"Springer"}],"recId":"1108007767","physDesc":[{"extent":"XXXVI, 803 S.","noteIll":"Ill., graph. Darst"}],"part":{"extent":"3","text":"(1994), Seite 575-577","pages":"575-577","year":"1994"},"type":{"bibl":"book"},"id":{"eki":["1108007767"],"isbn":["3540569510","0387569510"]},"disp":"Idarubicin/cytosine arabinoside and mitoxantrone/etoposide with rhGM-CSF priming for de novo acute myelogenous leukemiaAcute leukemias ; 4: Prognostic factors and treatment strategies","title":[{"title":"Prognostic factors and treatment strategies","subtitle":"with 286 tables / T. Büchner ... (ed.)"}]}],"recId":"1925769925","name":{"displayForm":["Rainer Haas, Werner Hunstein"]},"origin":[{"dateIssuedKey":"1994","dateIssuedDisp":"1994"}]} | ||
| SRT | |a HAASRAINERIDARUBICIN1994 | ||